Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Phathom Pharmaceuticals	Applied Therapeutics	Karyopharm Therapeutics	Cytokinetics	Gossamer Bio
Symbol	NASDAQ:PHAT	NASDAQ:APLT	NASDAQ:KPTI	NASDAQ:CYTK	NASDAQ:GOSS
Price Information
Current Price	$33.16	$33.49	$18.76	$12.01	$10.17
52 Week Range	Buy	Buy	Buy	Buy	Buy
Analyst Ratings
Consensus Recommendation	Buy	Buy	Buy	Buy	Buy
Consensus Price Target	$34.67	$54.00	$30.71	$22.17	$27.80
% Upside from Price Target	4.54% upside	61.24% upside	63.72% upside	84.57% upside	173.35% upside
Trade Information
Market Cap	$871.83 million	$699.94 million	$1.17 billion	$729.57 million	$696.57 million
Beta	N/A	N/A	1.69	1.18	0.67
Average Volume	92,011	192,218	1,702,803	919,264	499,606
Sales & Book Value
Annual Revenue	N/A	N/A	$40.89 million	$26.87 million	N/A
Price / Sales	N/A	N/A	30.07	26.58	N/A
Cashflow	N/A	N/A	N/A	N/A	N/A
Price / Cash	N/A	N/A	N/A	N/A	N/A
Book Value	$9.29 per share	N/A	$0.79 per share	($0.19) per share	$5.34 per share
Price / Book	N/A	N/A	23.75	-63.21	N/A
Profitability
Net Income	$-255,130,000.00	N/A	$-199,590,000.00	$-121,690,000.00	$-180,310,000.00
EPS	($13.98)	($3.55)	($3.22)	($2.11)	($3.29)
Trailing P/E Ratio	N/A	N/A	N/A	N/A	N/A
Forward P/E Ratio	N/A	N/A	N/A	N/A	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	N/A	N/A	-488.08%	-452.92%	N/A
Return on Equity (ROE)	N/A	N/A	-254.74%	-10,351.99%	-43.11%
Return on Assets (ROA)	N/A	N/A	-71.41%	-55.69%	-37.57%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.10%	N/A	2.47%	N/A	0.11%
Current Ratio	68.20%	N/A	6.01%	8.98%	11.09%
Quick Ratio	68.20%	N/A	6.00%	8.98%	11.09%
Ownership Information
Institutional Ownership Percentage	88.95%	20.92%	89.95%	92.57%	61.21%
Insider Ownership Percentage	N/A	N/A	11.63%	5.70%	23.30%
Miscellaneous
Employees	12	4	332	130	118
Shares Outstanding	28.97 million	21.97 million	65.55 million	59.46 million	66.34 million
Next Earnings Date	6/18/2020 (Estimated)	6/19/2020 (Estimated)	5/14/2020 (Estimated)	5/14/2020 (Estimated)	5/12/2020 (Estimated)
Optionable	Not Optionable	Not Optionable	Optionable	Optionable	Not Optionable

Comparison Ideas:

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

Start Your Free Trial Today

Market Data and Calendars

Investing Education and Resources